mRNA: A Versatile Molecule for Cancer Vaccines - PubMed (original) (raw)
Review
doi: 10.21775/cimb.022.113. Epub 2016 Nov 1.
Affiliations
- PMID: 27801664
- DOI: 10.21775/cimb.022.113
Free article
Review
mRNA: A Versatile Molecule for Cancer Vaccines
Mustafa Diken et al. Curr Issues Mol Biol. 2017.
Free article
Abstract
mRNA vaccines are finally ready to assume their rightful place at the forefront of nucleic acid- based vaccines. Major achievements within the last two decades have turned this highly versatile molecule into a safe and very attractive pharmaceutical platform that combines many positive attributes able to address a broad range of diseases, including cancer. The simplicity of mRNA vaccines greatly reduces complications generally associated with the production of biological vaccines. Intrinsic costimulatory and inflammatory triggers in addition to the provision of the antigenic information makes mRNA an all- in-one molecule that does not need additional adjuvants and that does not pose the risk of genomic integration. Clinical studies in various cancer types are moving forward and promising results with favorable clinical outcome are awaited. This review will recapitulate conceptual, mechanistic and immune-related features of this highly versatile molecule, elucidate how these features have been addressed in the past, and how comprehensive understanding can foster further optimization for broad application possibilities in cancer treatment.
Similar articles
- mRNA-based dendritic cell vaccines.
Benteyn D, Heirman C, Bonehill A, Thielemans K, Breckpot K. Benteyn D, et al. Expert Rev Vaccines. 2015 Feb;14(2):161-76. doi: 10.1586/14760584.2014.957684. Epub 2014 Sep 8. Expert Rev Vaccines. 2015. PMID: 25196947 Review. - The messenger's great message for vaccination.
Pascolo S. Pascolo S. Expert Rev Vaccines. 2015 Feb;14(2):153-6. doi: 10.1586/14760584.2015.1000871. Expert Rev Vaccines. 2015. PMID: 25586101 - mRNA Cancer Vaccines-Messages that Prevail.
Grunwitz C, Kranz LM. Grunwitz C, et al. Curr Top Microbiol Immunol. 2017;405:145-164. doi: 10.1007/82_2017_509. Curr Top Microbiol Immunol. 2017. PMID: 28401358 Review. - The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
Amanpour S. Amanpour S. Arch Razi Inst. 2021 Mar;76(1):1-6. doi: 10.22092/ari.2021.353761.1612. Epub 2021 Mar 1. Arch Razi Inst. 2021. PMID: 33818952 Free PMC article. - Highly potent mRNA based cancer vaccines represent an attractive platform for combination therapies supporting an improved therapeutic effect.
Fotin-Mleczek M, Zanzinger K, Heidenreich R, Lorenz C, Thess A, Duchardt KM, Kallen KJ. Fotin-Mleczek M, et al. J Gene Med. 2012 Jun;14(6):428-39. doi: 10.1002/jgm.2605. J Gene Med. 2012. PMID: 22262664
Cited by
- A Changing World in Gene Therapy Research: Exciting Opportunities for Medical Advancement and Biosafety Challenges.
Eisenman D, Debold S, Riddle J. Eisenman D, et al. Appl Biosaf. 2021 Dec 1;26(4):179-192. doi: 10.1089/apb.2021.0020. Epub 2021 Nov 24. Appl Biosaf. 2021. PMID: 36034096 Free PMC article. Review. - Potentialities and Challenges of mRNA Vaccine in Cancer Immunotherapy.
Duan LJ, Wang Q, Zhang C, Yang DX, Zhang XY. Duan LJ, et al. Front Immunol. 2022 May 26;13:923647. doi: 10.3389/fimmu.2022.923647. eCollection 2022. Front Immunol. 2022. PMID: 35711457 Free PMC article. Review. - RNA in Cancer Immunotherapy: Unlocking the Potential of the Immune System.
De Mey W, Esprit A, Thielemans K, Breckpot K, Franceschini L. De Mey W, et al. Clin Cancer Res. 2022 Sep 15;28(18):3929-3939. doi: 10.1158/1078-0432.CCR-21-3304. Clin Cancer Res. 2022. PMID: 35583609 Free PMC article. Review. - The clinical progress of mRNA vaccines and immunotherapies.
Barbier AJ, Jiang AY, Zhang P, Wooster R, Anderson DG. Barbier AJ, et al. Nat Biotechnol. 2022 Jun;40(6):840-854. doi: 10.1038/s41587-022-01294-2. Epub 2022 May 9. Nat Biotechnol. 2022. PMID: 35534554 Review. - Therapeutic Targeting of Alternative RNA Splicing in Gastrointestinal Malignancies and Other Cancers.
Sahin I, George A, Seyhan AA. Sahin I, et al. Int J Mol Sci. 2021 Oct 30;22(21):11790. doi: 10.3390/ijms222111790. Int J Mol Sci. 2021. PMID: 34769221 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous